UltraChoice 7

Manufacturer: Pfizer Animal Health

Clostridium Chauvoei-Septicum-Novyi-Sordellii-Perfringens Types C & D Bacterin-Toxoid

U.s. Vet. Lic. No.

189

Description

This product consists of killed, standardized cultures of Clostridium chauvoei, Cl. septicum, Cl. novyi, Cl. sordellii, and Cl. perfringens types C and D, with a special, water-soluble adjuvant (Stimugen™).

Contains formalin as preservative.

UltraChoice 7 Indications

For use in healthy cattle and sheep as an aid in preventing blackleg caused by Cl. chauvoei; malignant edema caused by Cl. septicum; black disease caused by Cl. novyi; gas-gangrene caused by Cl. sordellii; and enterotoxemia and enteritis caused by Cl. perfringens types B, C, and D. Although Cl. perfringens type B is not a significant problem in North America, immunity is provided by the beta toxoid of type C and the epsilon toxoid of type D.

Directions

Shake well. Cattle: Aseptically administer 2 mL. In accordance with Beef Quality Assurance guidelines, this product should be administered subcutaneously (SC) under the skin. Healthy cattle should receive 2 doses administered 4-6 weeks apart. Sheep: Aseptically administer 1 mL subcutaneously in the neck, followed by a second dose 4-6 weeks later. Annual revaccination with a single dose is recommended.

Precaution(s)

Store at 2°-7°C. Do not freeze. Use entire contents when first opened.

UltraChoice 7 Caution(s)

Temporary local swelling at injection site may occur after administration. As with many vaccines, anaphylaxis may occur after use. Initial antidote of epinephrine is recommended and should be followed with appropriate supportive therapy.

Warning(s)

Do not vaccinate within 21 days before slaughter.

For veterinary use only.

85-5064-01

Presentation

10 doses, 50 doses and 250 doses.

Nac No.

36900760